Thermo Fisher Scientific/$TMO
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Thermo Fisher Scientific
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Ticker
$TMO
Sector
Primary listing
NYSE
Employees
125,000
Headquarters
Website
TMO Metrics
BasicAdvanced
$178B
27.33
$17.30
0.75
$1.64
0.36%
Price and volume
Market cap
$178B
Beta
0.75
52-week high
$614.04
52-week low
$385.46
Average daily volume
1.7M
Dividend rate
$1.64
Financial strength
Current ratio
1.933
Quick ratio
1.178
Long term debt to equity
65.244
Total debt to equity
69.62
Dividend payout ratio (TTM)
9.26%
Interest coverage (TTM)
5.76%
Profitability
EBITDA (TTM)
10,827
Gross margin (TTM)
41.28%
Net profit margin (TTM)
15.24%
Operating margin (TTM)
18.39%
Effective tax rate (TTM)
6.21%
Revenue per employee (TTM)
$350,000
Management effectiveness
Return on assets (TTM)
4.97%
Return on equity (TTM)
13.42%
Valuation
Price to earnings (TTM)
27.328
Price to revenue (TTM)
4.156
Price to book
3.54
Price to tangible book (TTM)
-15.02
Price to free cash flow (TTM)
29.109
Free cash flow yield (TTM)
3.44%
Free cash flow per share (TTM)
16.237
Dividend yield (TTM)
0.35%
Forward dividend yield
0.36%
Growth
Revenue change (TTM)
2.05%
Earnings per share change (TTM)
7.24%
3-year revenue growth (CAGR)
0.30%
10-year revenue growth (CAGR)
9.87%
3-year earnings per share growth (CAGR)
-2.72%
10-year earnings per share growth (CAGR)
13.47%
3-year dividend per share growth (CAGR)
13.56%
10-year dividend per share growth (CAGR)
10.58%
What the Analysts think about TMO
Analyst ratings (Buy, Hold, Sell) for Thermo Fisher Scientific stock.
Bulls say / Bears say
Thermo Fisher exceeded second-quarter expectations, posting adjusted EPS of $5.36 against $5.22 and revenue of $10.85 billion—up 3%—driven by strong laboratory product sales and smoother supply chains (Reuters)
The acquisition of Sanofi’s Ridgefield, New Jersey, sterile fill-finish and packaging site will expand Thermo Fisher’s contract manufacturing capabilities in the U.S., supporting its biopharma partnerships and underpinning long-term revenue growth (Reuters)
Thermo Fisher’s move to divest roughly $4 billion in slow-growing diagnostics assets, including its microbiology business, is expected to free up capital for higher-margin investments in bioprocessing and life science solutions (Reuters)
Organic revenue growth remained subdued at just 3% in the second quarter, falling short of historical mid-single-digit levels and raising questions about sustained end-market demand (Reuters)
Thermo Fisher’s recent $1.3 billion bond issuance, rated Baa1/A–, highlights greater reliance on debt to finance acquisitions, which may weigh on its credit profile and limit financial flexibility (Reuters)
Thermo Fisher continues to face margin pressure and revised profit forecasts as U.S.–China trade tensions force higher prices and threaten demand (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2025.
TMO Financial Performance
Revenues and expenses
TMO Earnings Performance
Company profitability
TMO News
AllArticlesVideos
Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel
Business Wire3 days ago
Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin for Enhanced Bioprocessing Performance
Business Wire3 days ago
Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield, New Jersey Site
Business Wire2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Oct15
Thermo Fisher Scientific
DividendPayment
$0.43Per share
FAQs
What’s the current market cap for Thermo Fisher Scientific stock?
Thermo Fisher Scientific (TMO) has a market cap of $178B as of September 18, 2025.
What is the P/E ratio for Thermo Fisher Scientific stock?
The price to earnings (P/E) ratio for Thermo Fisher Scientific (TMO) stock is 27.33 as of September 18, 2025.
Does Thermo Fisher Scientific stock pay dividends?
Yes, the Thermo Fisher Scientific (TMO) stock pays dividends to shareholders. As of September 18, 2025, the dividend rate is $1.64 and the yield is 0.36%. Thermo Fisher Scientific has a payout ratio of 9.26% on a trailing twelve-month basis.
When is the next Thermo Fisher Scientific dividend payment date?
The next Thermo Fisher Scientific (TMO) dividend payment is scheduled for October 15, 2025.
What is the beta indicator for Thermo Fisher Scientific?
Thermo Fisher Scientific (TMO) has a beta rating of 0.75. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.